Also trades as: DSNKY (OTC) · $vol 4M · DSKYF (OTC) · $vol 0M

¥2,709.00 ($17.16)

-31.50 (-1.15%)

Weekly Expected Move ±3.9%

¥2499 ¥2604 ¥2709 ¥2814 ¥2919

JPX · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 38 · ¥4.93T mcap · 1.82B float · 0.374% daily turnover

Revenue

$2.12T +12.6% ▲

5Y CAGR: +17.1%

Gross Profit

$1.45T -1.1% ▼

5Y CAGR: +18.4%

Operating Income

$207.3B -31.6% ▼

5Y CAGR: +10.2%

Net Income

$259.9B -12.1% ▼

5Y CAGR: +27.9%

EPS (Diluted)

$140.37 -9.9% ▼

5Y CAGR: +29.1%

EBITDA

$348.9B -8.3% ▼

5Y CAGR: +23.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.04T	$1.28T	$1.60T	$1.89T	$2.12T
YoY Growth	+8.6%	+22.4%	+25.3%	+17.8%	+12.6%
Cost of Revenue	$353.3B	$363.5B	$415.3B	$415.8B	$669.0B
Gross Profit	$691.6B	$915.0B	$1.19T	$1.47T	$1.45T
Gross Margin	66.2%	71.6%	74.1%	78.0%	68.5%
R&D Expenses	$260.2B	$341.6B	$365.2B	$436.0B	$466.0B
SG&A Expenses	$358.3B	$471.2B	$637.0B	$731.2B	$780.7B
Operating Expenses	$545.5B	$812.8B	$1.00T	$1.17T	$1.25T
Operating Income	$146.1B	$102.2B	$184.2B	$303.3B	$207.3B
Operating Margin	14.0%	8.0%	11.5%	16.1%	9.8%
Interest Expense	$1.9B	$2.8B	$4.2B	$3.4B	$8.0B
Income Before Tax	$73.5B	$126.9B	$237.2B	$355.6B	$263.4B
Tax Expense	$6.5B	$17.7B	$36.2B	$59.9B	$3.6B
Net Income	$67.0B	$109.2B	$200.7B	$295.8B	$259.9B
Net Margin	6.4%	8.5%	12.5%	15.7%	12.2%
EPS (Diluted)	$34.91	$56.91	$104.62	$155.87	$140.37
EBITDA	$131.3B	$169.7B	$271.1B	$380.6B	$348.9B
Shares Outstanding	1.92B	1.92B	1.92B	1.90B	1.85B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$436.2B	$446.6B	$484.8B	$518.7B	$474.6B	$500.8B	$558.1B	$589.6B
Cost of Revenue	$95.0B	$98.0B	$128.4B	$94.3B	$92.3B	$156.0B	$118.3B	$302.4B
Gross Profit	$341.1B	$348.5B	$356.5B	$424.4B	$382.3B	$344.8B	$439.8B	$287.1B
Gross Margin	78.2%	78.0%	73.5%	81.8%	80.5%	68.9%	78.8%	48.7%
R&D Expenses	$100.7B	$92.6B	$109.3B	$133.4B	$106.0B	$111.7B	$122.1B	$126.2B
SG&A Expenses	$175.1B	$162.2B	$185.6B	$208.2B	$180.3B	$189.1B	$228.2B	$183.0B
Operating Expenses	$248.1B	$282.5B	$295.0B	$369.4B	$285.5B	$300.8B	$350.3B	$309.2B
Operating Income	$93.0B	$66.0B	$61.4B	$55.0B	$96.7B	$44.0B	$89.5B	-$22.1B
Operating Margin	21.3%	14.8%	12.7%	10.6%	20.4%	8.8%	16.0%	-3.7%
Interest Expense	$2.0B	$10.2B	$0	$7.1B	$1.4B	$834M	$2.2B	$3.6B
Income Before Tax	$110.2B	$82.4B	$82.4B	$80.6B	$105.4B	$57.8B	$106.7B	-$6.5B
Tax Expense	$24.8B	$21.1B	$20.5B	-$6.5B	$19.9B	$12.5B	$20.1B	-$48.9B
Net Income	$85.4B	$61.3B	$61.9B	$87.2B	$85.5B	$45.3B	$86.6B	$42.4B
Net Margin	19.6%	13.7%	12.8%	16.8%	18.0%	9.0%	15.5%	7.2%
EPS (Diluted)	$44.57	$32.18	$32.75	$46.31	$46.01	$24.48	$46.76	$23.09
EBITDA	$109.6B	$110.6B	$78.8B	$81.6B	$114.5B	$77.1B	$128.3B	$18.2B
Shares Outstanding	1.92B	1.92B	1.89B	1.88B	1.86B	1.85B	1.85B	1.84B

4568.T JPX